Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
Clinical trial NCT00911911 · COMPLETED
Trial details
- NCT number
- NCT00911911
- Sponsor
- Centre Oscar Lambret
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-22
- Primary completion
- 2009-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.